Endo Exam 2 MED CHEM Word Scramble
|
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
| Question | Answer |
| WHAT SECRETES INSULIN | BETA CELLS OF ISLET OF LANGERHANS |
| SHORT ACTING INSULIN | HUMILIN R, NOVOLIN R |
| SHORT ACTING INSULIN ONSET OF ACTION AND DURATION | OA: 0.5-1 HR DOA: 6-8 HR |
| RAPID ACTING INSULIN | LISPRO (HUMALOG) ASPART (NOVOLOG) GLULISINE (APIDRA) |
| RAPID ACTING INSULIN ONSET OF ACTION AND DURATION | OA: 15 MIN DOA: 4 HR |
| LISPRO (HUMALOG) SEQUENCE CHANGES (2) | B28 PRO -> LYS B29 LYS -> PRO |
| ASPART( NOVOLOG) SEQUENCE CHANGE | B28 PRO -> ASP |
| GLULISINE (APIDRA) SEQUENCE CHANGES (2) | B3 ASN -> LYS B29 LYS -> GLU |
| WHAT MAKES RAPID INSULIN HAVE A FAST DURATION OF ACTION? | EXIST AS MONOMERS |
| WHATS THE NAME OF THE INHALED INSULIN? DURATION? CONTRAINDICATION? | -AFREZZA -90-270 MIN - CHRONIC LUNG DISEASE/ BRONCHO SPASMS |
| INTERMEDIATE-ACTING INSULIN | HUMULIN N NOVOLIN N |
| INTERMEDIATE ACTING INSULIN IS COMPLEXED WITH WHAT ? (2) | PROTAMINE (POSITIVELY CHARGED) AND REGULAR INSULIN (HUMILIN AND NOVOLIN R) |
| WHAT IS THE INTERMEDIATE ACTING INSULIN APPEARANCE? ONSET OF ACTION? DURATION? | CLOUDY OA: 2 HR DOA; 12-18 HR |
| LONG ACTING INSULIN | GLARGINE (LANTUS) DETEMIR ( LEVEMIR) DEGLUDEC (TRESIBA) |
| WHAT SEQUENCE CHANGES OCCUR IN GLARGINE (LANTUS)? | GLYSINE & ARGININE |
| WHAT MAKES GLARGINE LONG ACTING ? | PH4 IN SOLUTION BUT WHEN INJECTED AT BODY PH IT PRECIPITATES AND TAKES LONGER TO BE RELEASED |
| GLARGINE ONSET AND DOA | OA: 2 HR DOA;20-24 HR |
| WHAT SEQUENCE CHANGE OCCURS IN DETEMIR ? | ADD C14 FATTY ACID (MYRISTIC ACID) TO B 29 LYS AND BINDS TO ALBUMIN AND LONGER ACTION |
| DETEMIR ONSET AND DOA? | OA: 2HR DOA : 12-24 |
| WHAT SEQUENCE OCCURS TO DEGLUDEC ? | REMOVAL OF THREONINE AND ADD GLUTAMIC ACID AND HEXADECANEDIOIC FATTY ACID |
| DEGLUDEC OA & DOA | OA: 1 HR DOA: > 24 HRS ULTRA LONG INSULIN |
| WHAT MEDICATIONS CAN CAUSE HYPERGLYCEMIA? (5) | -GLUCOCORTICOIDS -NIACIN -DIURETICS (THIAZIDES) -HYDANTOINS (PHENYTOIN) -ATYPICAL ANTIPSYCHOTICS |
| WHAT MEDICATIONS CAN CAUSE HYPOGLYCEMIA? (3) | -PO DIABETIC MEDS -ACEi -SALICYLATES |
| WHAT IS INSULIN? | PEPTIDE |
| IS GLP-1 A DRUG BY ITSELF? WHAT SECRETES INCRETIN? | NO INTESTINAL L-CELLS |
| WHAT HYDROLYZES GLP-1? | DPP-IV (DIPEPIDYLPROTEASE) |
| WHAT EFFECT DOES GLP-1 HAVE ON INSULIN AND GLUCAGON AND FOOD INTAKE, BLOOD GLUCOSE | -INCREASES INSULIN SECRETION -DECREASES GLUCAGON RELEASE -DECREASE FOOD INTAKE -DELAYS GASTRIC EMPTYING -DECREASES BLOOD GLUCOSE |
| HOW MANY AA PEPTIDES DOES GLP-1 HAVE? | 37 INCRETIN HORMONES |
| WHERE DOES THE ENZYME DPP-IV CLEAVE TO HYDROLYZE GLP-1? | BETWEEN 8 ALA & 9 GLU |
| GLP-1 BBW? | RISK OF THYROID TUMORS |
| WHAT IS THE EXENATIDE HOMOLOGY PERCENTAGE | 53% |
| EXENATIDE ER (BYDUREON) LASTS 2 WEEKS BECAUSE ITS FORMULATED AS? | MICROSPHERES |
| WHAT MAKES LIRAGLUTIDE NOT HYDRALYZABLE BY DPP-IV AND LASTS 13 HOURS? | ADDITION OF C16 FATTY ACID CHAIN ATTACH TO 2 LYS |
| WHAT MAKES DULAGLUTIDE NOT HYDRALYZABLE BY DPP-IV AND LASTS 5 DAYS? HOW OFTEN IS IT ADMINISTERED? | -GLP-1 ANALOG + LINKER + MODIFIED IgG4 FC DOMAIN -ONCE A WEEK |
| (1) WHAT AA SEQUENCE CHANGE OCCURS IN SEMAGLUTIDE? | AA 8 ALANINE CHANGES TO ALPHA-AMINOISOBUTYRIC ACID BY STERIC HINDRANCE AND CANT BE HYDROLYZED BY DPP-IV |
| (2) WHAT AA SEQUENCE CHANGE OCCURS IN SEMAGLUTIDE? | AA 26 LYS ATTATCHED TO SPACER AND CONTAINS C-18 FATTY DI-ACID CHAIN |
| HOW IS SEMAGLUTIDE ORAL FORMULATED? | -WHEN SEMAGLUTIDE GETS TO THE STOMACH IT STARTS TO DISSOLVE AND RELEASES SNAC. SNAC RAISES LOCAL PH AND PREVENTS DEGRADATION OF SEMAGLUTIDE. |
| WHAT CLASS DOES TIRZEPATIDE BELONG TO ? HOW OFTEN IS IT ADMINISTERED? | GLP-1 AGONIST AND GIP ONCE A WEEK |
| WHAT RELEASES PRAMLINTIDE ? WHAT IS COSECRETED WITH PRAMLINTIDE? | -BETA CELLS -INSULIN |
| IS PRAMLINTIDE SUITABLE AS A DRUG? | NO |
| WHAT ROLES DO AMYLIN AGONIST PLAY? | - SUPPRESS GLUCAGON SECRETION -REGULATE FOOD INTAKE |
| SUBSTITUTION WITH PROLINE IN PRAMLINTIDE HAS WHAT EFFECT ON WATER SOLUBILITY AND SELF-AGGREGATION? | -INCREASE -DECREASE |
| WHERE DO SULFONYLUREAS BIND TO? WHAT DO THEY STIMULATE TO RELEASE? | -SUR OF THE ATP-SENSITIVE K CHANNELL ON BETA CELLS -INSULIN |
| WHERE ELSE DO SULFONYLUREAS BIND THAT THEY CAUSE SIDE EFFECTS SUCH AS CARDIAC EFFECTS? | -CARDIAC AND SMOOTH MUSCLES |
| SECOND GEN SULFONYLUREAS ARE MORE BULKY, POTENT AND CONTAIN CYCLIC ALIPHATIC GROUPS TRUE OR FALSE? | TRUE |
| SULFONAMIDES ARE HIGHLY PROTEIN BOUND, WHAT HAPPENS WHEN YOU COMBINE DRUGS SUCH AS WARFARIN, SALICYLATES WITH SULFONYLUREAS? | THEY WILL DISPLACE SULFONYLUREAS AND CREATE MORE FREE FORM DRUG AND RESULT IN HYPOGLYCEMIA |
| WHAT 2 DRUGS ARE MEGLITINIDES? | -REPAGLINIDE -NATEGLINIDE |
| WHAT IS THE DOA FOR SULFONYLUREAS | ABOUT 24 HOURS |
| WHAT IS THE DOA FOR MEGLITINIDES? | 4-6 HOURS |
| MEGLITINIDES CAN CUASE HYPOGLYCEMIA TRUE OR FALSE? | TRUE, BUT FOR A SHORTER PERIOD OF TIME |
| WHERE DOES NATEGLINIDE BINDS SELECTIVELY AT? MORE OR LESS CV SIDE EFFECTS? | -SUR1 ON BETA CELLS OF PANCREAS -LESS SIDE EFFECTS |
| HOW IS METFORMIN TRANSPORTED? | ORGANIC CATION TRANSPORTER (OCT) |
| METFORMIN SERIOUS BUT RARE SE? -WHO HAS HIGHER RISK? | -LACTIC ACIDOSIS - RENAL OR HEPATIC IMPAIREMENT, ALCOHOL ABUSE, CHF |
| METFORMIN DDI WITH THIS DRUG DUE TO BOTH USING OCT? (INCREASES METFORMIN CONCENTRATION) | CIMETIDINE (ANTIHISTAMINE) |
| METFORMIN IS CI WITH ? | IODINATED CONTRAST AGENTS |
| MOA OF THIAZOLIDINEDIONES (TZD) PIOGLITAZONES | PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR-Y) STIMULATION |
| ACTOS HAS DDI WITH WHICH CYPS? | -2C8 INHIBITOR GEMFIBROZIL -2C8 INDUCER RIFAMPIN |
| ACTOS SE ? | -CHF -WEIGHT GAIN -EDEMA -BONE FRACTURES IN FEMALES |
| DPP-IV INHIBITORS END IN ? | GLIPTIN |
| INCRETIN HORMONES (2) | -GLP-1 -GIP |
| SITAGLIPTIN | JANUVIA |
| SAXAGLIPTIN CONTAINS WHAT GROUP TO INCREASE LIPOPHILICITY? WHAT BOND DOES IT FORM WITH SER 630? BRAND NAME? | -ADAMANTYL (HAT) -COVALENT IRREVERSIBLE -ONGLYZA |
| LINAGLIPTIN BRAND NAME DOES IT NEED TO BE DOSE ADJUSTED? | -TRADJENTA -NO BECAUSE MOST ELIMINATED IN FECES |
| ALOGLIPTIN BRAND NAME? | NESINA |
| ALPHA GLUCOSIDASE INHIBITORS PREVENT THE HYDROLYSIS OF CARBOHYDRATES TRUE OR FALSE? | TRUE |
| ACARBOSE BRAND NAME | PRECOSE |
| MIGLITOL BRAND NAME | GLYSET |
| WHERE DO SGLT2 WORK? HOW DO THEY WORK? | -KIDNEYS - BLOCK THE EABSORPTION OF SODIUM AND GLUCOSE AND EXCRETES IT IN URINE |
| WHAT IS THE LEAD MOLECULE FOR SGLT2 | PHORIZIN |
| HOW MANY CARBONS DOES GLUCOSE CONTAIN? | 6 |
| SGLT2 EFFECTS? | -WEIGHT LOSS -UTI -PLYURIA -GENITOURINARY INFECTION |
| SGLT2 MORE SEVERE SIDE EFFECT | KETOACIDOSIS |
| CANAGLIFLOZIN BRAND NAME | INVOKANA |
| DAPAGLIFLOZIN BRAND NAME | FARXIGA |
| WHAT STRUCTURE DO ALL SGLT2 HAVE? | MODIFIED GLUCOSE |
| EMPAGLIFLOZIN BRAND NAME | JARDIANCE |
| ERTUGLIFLOZIN BRAND NAME | STEGLATRO |
| WHAT TYPE OF METABOLISM DO SGTL2 UNDERGO? WHERE ON THE STRUCTURE? | -O-GLUCURONIDATION -SUGAR |
| SGLT2 CAN BE USED FOR HF TRUE OR FALSE | TRUE |
| WHICH SGTL2 INHIBITOR REDUCE THE RISK OF HEART FAILURE? | SOTAGLIFLOZIN |
| SGLT2 CAN BE USED FOR HF TRUE OR FALSE | TRUE |
| WHICH SGTL2 INHIBITOR REDUCE THE RISK OF HEART FAILURE? | SOTAGLIFLOZIN |
Created by:
maarment